Kate Crawford writing for Nature: Lessons from clinical trials show why regulation is important. Federal requirements and subsequent advocacy have made many more clinical-trial data available to the public and subject to rigorous verification. This becomes the bedrock for better policymaking and public trust. Regulatory oversight of affective technologies would bring similar benefits and accountability. … Continue reading Time to regulate AI interpreting emotions? →